Gsk (GSK) Change in Cash (2009 - 2026)

Gsk's Change in Cash history runs 18 years deep, the most recent figure standing at -$71.5 million for Q1 2026.

• In Q1 2026, Change in Cash fell 106.6% year-over-year to -$71.5 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 123.82% YoY), while the FY2025 annual figure was -$233.4 million, down 130.48% from the prior year.
• Change in Cash for Q1 2026 stood at -$71.5 million, down from -$55.9 million in the prior quarter.
• The five-year high for Change in Cash was $9.3 billion in Q1 2022, with the low at -$818.0 million in Q1 2023.
• The 5-year median for Change in Cash is -$55.9 million (2025), against an average of $1.4 billion.
• The sharpest annual moves came in 2022 and 2025: Change in Cash soared 716.27% in 2022, then sank 190.68% in 2025.
• Gsk's Change in Cash stood at $4.1 billion in 2022, then slumped by 108.97% to -$371.1 million in 2023, then surged by 116.6% to $61.6 million in 2024, then tumbled by 190.68% to -$55.9 million in 2025, then dropped by 27.9% to -$71.5 million in 2026.
• Business Quant data shows GSK's Change in Cash at -$71.5 million in Q1 2026, -$55.9 million in Q4 2025, and $1.1 billion in Q1 2025.